CSI Market
Sign In | Register

Diplomat Pharmacy Inc (DPLO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access DPLO Annual Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Diplomat Pharmacy Inc's cash-generating activities.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2019)
9 Months 		(Jun 30 2019) (Mar 31 2019) (Dec 31 2018) (Sep 30 2018)
Operating Activities
Income-351.04
Depreciation & amortization58.52
Amortization of Other Assets3.10
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges297.17
Provision For Loan Losses Expensed9.09
Increase (Decrease) in Inventories29.67
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation12.63
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Temporary Equity Accretion To Redemption Value Adjustment-
Payments For Settlement Of Claim Operating Activities14.10
Write Off Of Deferred Debt Issuance Cost0.73
Increase Decrease In Rebates Payable0.20
Income taxes-1.33
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-13.87
Increase (Decrease) in Accounts Payable57.76
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Assets Held-for-sale1.65
Other Working Capital5.07
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-15.40
Discontinued operations0.00
Net Cash flow from Operating Activities108.05
Investing Activities
Capital Expenditures-18.01
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Repayment Of Notes Receivable From Related Parties-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-7.05
Payments to Acquire Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.02
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-25.04
Financing Activities
Short-term debt Net-71.30
Other borrowing transactions-2.47
Long-term debt - borrowings0.00
Long-term debt - repayments-8.63
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.60
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments Associated With Stock And Stock Option Redemptions-
Contingent Consideration Payment Noncurrent-2.28
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-84.07
Effect of exchange rate on cash flow-1.07
Discontinued operations0.00
Free Cash Flow90.03
Total Cash Flow-1.07
4 historic quarters locked

Sign in to unlock the full Diplomat Pharmacy Inc cash flow history.

Sign In Create Free Account

About DPLO Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.